You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Boehringer Ingelheim in Consumer Health

Oct 2011

Price: US$525

About this Report

About this Report


Euromonitor International's report on Boehringer Ingelheim GmbH delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.

Company and market share data provide a detailed look at the financial position of Boehringer Ingelheim GmbH, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Boehringer Ingelheim GmbH This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Boehringer Ingelheim GmbH provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

Strategic Evaluation

Key company facts

Expansion of key brands helps drive consumer health

SWOT: Boehringer Ingelheim GmbH

Key strategic objectives and challenges

Competitive Positioning

Digestive remedies and analgesics dominate performance

Consumer health remains fragmented

Cough, cold and allergy remedies crucial for Boehringer

Reliance on Japan may hurt Boehringer

Geographic Opportunities

Strength in Brazil: weakness in China

Declining category sales and production interruptions

Select opportunities in Japan at product level

PPI presents direct threat to H2 blockers in mature markets

Focus on cough remedies means loss of opportunities

Create umbrella brand in analgesics

Pharmaton : Boehringer flagship brand

Product Opportunities

PPI: where to launch

A view on PPI

Consider Antistax for additional backing in new markets

Look to expand beyond cough remedies

Brand and Private Label Strategy

Multivitamin focus and lack of regional diversity

Mucosolvan : Boehringer strength in cough remedies

Buscopan : educating public on IBS treatment

Operations

Research and development , production and distribution

Recommendations

Key recommendations

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!